Skip to main content
. 2019 Nov 25;34(1):10. doi: 10.4102/sajid.v34i1.10

FIGURE 3.

FIGURE 3

(a) Kaplan–Meier function of time to isoniazid preventive therapy initiation by predictor variables. Age group (c) and duration of antiretroviral therapy (d) were important determinants of isoniazid preventive therapy initiation, while gender (b) was not. Baseline World Health Organization clinical stage (e), median viral load (f), district category (g) and adherence (h) were all important predictors of isoniazid preventive therapy initiation.